Recent findings using multiplex biomarker approaches suggest that, even with widely, repeatedly studied biomarkers (eg, NfL),18, 19, 20, 21 treatment strategies may require alternative or dual treatments to tackle complex, multidimensional pathologies observed in neurodegenerative diseases. Here, NEFL is linked to neurodegenerative disease.